Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

94 trials

NCT06680037
Recruiting
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Phase 1 · United States · 8 sites
Registry update: 27 Oct 2026
NCT06626919
Recruiting
Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
Phase 1 · United States · 14 sites
Registry update: 22 Oct 2026
NCT06342544
Recruiting
Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
Phase 3 · France · 11 sites
Registry update: 21 Jan 2026
NCT06909214
Recruiting
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
Phase 4 · United States · 18 sites
Registry update: 10 Mar 2026
NCT07022197
Recruiting
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/2 · China · 1 site
Registry update: 16 Oct 2026
2024-516015-24-00
Recruiting
Efficacy and tolerability of efgartigimod as early treatment in patients with generalized myasthenia gravis.
Phase 4 · Spain · 1 site
Registry update: 5 Dec 2024
NCT06743490
Recruiting
Capturing Key MG-symptoms Using Smartphone Recordings.
Not applicable · Netherlands · 1 site
Registry update: 8 Jul 2026
NCT06860633
Recruiting
Treatment of Myasthenia Gravis Exacerbation or Crisis With Efgartigimod
Phase 4 · United States · 1 site
Registry update: 11 Jul 2025
NCT06688435
Recruiting
A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis
Phase 1 · China · 1 site
Registry update: 12 Aug 2026
NCT06815133
Recruiting
Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months
Not applicable · France · 1 site
Registry update: 3 Dec 2025
NCT06866483
Recruiting
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
Not applicable · United States · 1 site
Registry update: 10 Mar 2025
2023-506656-24-00
Recruiting
Immediate corticosteroid therapy and rituximab to prevent generalization in ocular myasthenia gravis: a PROBE-type multicenter, open-label, randomized controlled trial
Phase 3 · France · 11 sites
Registry update: 6 Jun 2025
NCT06765161
Recruiting
Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
Phase 3 · Canada · 1 site
Registry update: 22 Oct 2026
NCT06359041
Recruiting
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Phase 1/2 · United States · 17 sites
Registry update: 19 Oct 2026
NCT06312644
Recruiting
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Not applicable · Australia, Germany, France, United Kingdom, Italy, South Korea, United States · 7 sites
Registry update: 16 Apr 2026
NCT06607627
Recruiting
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
Phase 3 · Brazil, Japan, Poland, Taiwan, United States · 10 sites
Registry update: 1 Apr 2026
NCT06941584
Recruiting
Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
Not applicable · Italy · 1 site
Registry update: 24 Apr 2025
NCT06298565
Recruiting
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
Not applicable · Austria, Belgium, Germany, Spain, Italy, United States · 35 sites
Registry update: 17 Feb 2026
NCT06055959
Recruiting
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Phase 2/3 · United Kingdom, Italy, South Korea, Poland, United States · 9 sites
Registry update: 5 Nov 2026
NCT06491238
Recruiting
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
Not applicable · United States · 1 site
Registry update: 23 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.